Fig. 7From: Predicted antiviral drugs Darunavir, Amprenavir, Rimantadine and Saquinavir can potentially bind to neutralize SARS-CoV-2 conserved proteins 3D-binding interfaces of NSP7-8–12 complex with Amprenavir, Darunavir, Rimantadine &Saquinavir. a–c Binding motifs of Amprenavir. d All the binding motifs of Amprenavir together. e–h Binding interfaces of Darunavir. i Combined binding motifs of Darunavir. j, k Rimantadine binding motifs. l–n Saquinavir binding motifs. o Combined motifs of ROC. Numbers indicate the motif forming amino acids. Three letter codes of amino acids have been mentionedBack to article page